Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc/ US98956P1021 /
ZBH
|
10/3/2023 9:59:54 PM
|
Chg.
-1.07
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
110.35USD
|
-0.96%
|
94,045
Turnover: 10.3 mill. |
-Bid Size: - |
-Ask Size: - |
23.05 bill.USD |
0.87% |
100.29 |
Fundamentals
| |
FY 2022 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
1.10 USD |
-43.01% |
| EPS Diluted: |
1.10 USD |
-42.41% |
| Revenues per Share: |
33.21 USD |
-11.35% |
| Book Value per Share: |
57.55 USD |
-4.96% |
| Cash Flow per Share: |
6.49 USD |
-9.45% |
| Dividend per Share: |
0.96 USD |
0.00% |
| Total |
in mill. |
|
| Revenues: |
6,939.90 USD |
-11.44% |
| Net Income: |
231.40 USD |
-42.38% |
| Operating Cash Flow: |
1,356.20 USD |
- |
| Cash and Cash Equivalents: |
375.70 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
100.29 |
115.91 |
| P/S Ratio: |
3.32 |
3.84 |
| P/BV ratio: |
1.92 |
2.22 |
| P/CF Ratio: |
17.00 |
19.65 |
| PEG: |
-2.33 |
-2.70 |
| Earnings Yield: |
1.00% |
0.86% |
| Dividend Yield: |
0.87% |
0.75% |
| Market Capitalization |
|
| Market Capitalization: |
23.05 bill. USD |
26.64 bill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
208.96 mill. |
|
Profitability
| Gross Profit Margin: |
70.90% |
| EBIT Margin: |
10.03% |
| Net Profit Margin: |
3.33% |
| Return on Equity: |
1.92% |
| Return on Assets: |
1.10% |
Financial Strength
| Liquidity I / Cash Ratio: |
15.93% |
| Liquidity II / Quick Ratio: |
74.51% |
| Liquidity III / Current Ratio: |
187.74% |
| Debt / Equity Ratio: |
75.16% |
| Dynam. Debt / Equity Ratio: |
666.49% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
12/31/2022 |
| Accounting Standard: |
US GAAP |